Cargando…

Virally mediated optogenetic excitation and inhibition of pain in freely moving non-transgenic mice

Primary nociceptors are the first neurons involved in the complex processing system that regulates normal and pathological pain(1). Our ability to excite and inhibit these neurons has been limited by pharmacological and electrical stimulation constraints; non-invasive excitation and inhibition of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Shrivats Mohan, Montgomery, Kate L., Towne, Chris, Lee, Soo Yeun, Ramakrishnan, Charu, Deisseroth, Karl, Delp, Scott L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988230/
https://www.ncbi.nlm.nih.gov/pubmed/24531797
http://dx.doi.org/10.1038/nbt.2834
Descripción
Sumario:Primary nociceptors are the first neurons involved in the complex processing system that regulates normal and pathological pain(1). Our ability to excite and inhibit these neurons has been limited by pharmacological and electrical stimulation constraints; non-invasive excitation and inhibition of these neurons in freely moving non-transgenic animals has not been possible. Here we use an optogenetic(2) strategy to bidirectionally control nociceptors of non-transgenic mice. Intra-sciatic nerve injection of adeno-associated viruses encoding an excitatory opsin enabled light-inducible stimulation of acute pain, place aversion, and optogenetically mediated reductions in withdrawal thresholds to mechanical and thermal stimuli. In contrast, viral delivery of an inhibitory opsin enabled light-inducible inhibition of acute pain perception, and reversed mechanical allodynia and thermal hyperalgesia in a model of neuropathic pain. Light was delivered transdermally enabling these behaviors to be induced in freely moving animals. This approach may have utility in basic and translational pain research, and enable rapid drug screening and testing of newly engineered opsins.